Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.88
-0.57 (-2.24%)
At close: Nov 19, 2025, 4:00 PM EST
24.87
-0.01 (-0.04%)
After-hours: Nov 19, 2025, 7:59 PM EST
Pfizer Revenue
Pfizer had revenue of $16.65B in the quarter ending September 28, 2025, a decrease of -5.92%. This brings the company's revenue in the last twelve months to $62.79B, up 3.89% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.79B
Revenue Growth
+3.89%
P/S Ratio
2.25
Revenue / Employee
$775,123
Employees
81,000
Market Cap
141.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PFE News
- 5 hours ago - October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs - Seeking Alpha
- 7 hours ago - Pfizer: Is This Pharma Giant Finally A Bargain - Seeking Alpha
- 13 hours ago - Pfizer in $41.5 million settlement with Texas over ADHD drug - Reuters
- 16 hours ago - Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 1 day ago - Why biotech and drug stocks are on the mend even though the rest of the market is hurting - Market Watch
- 1 day ago - Global drugmakers rush to boost US presence as tariff threat looms - Reuters
- 2 days ago - US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says - Reuters
- 2 days ago - 3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List - Seeking Alpha